Jonathan Drachman

2020 - Aquinox Pharmaceuticals

In 2020, Jonathan Drachman earned a total compensation of $4.5M as Chief Executive Officer at Aquinox Pharmaceuticals, a 17% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$219,680
Salary$418,750
Stock Awards$3,830,108
Total$4,468,538

Drachman received $3.8M in stock awards, accounting for 86% of the total pay in 2020.

Drachman also received $219.7K in non-equity incentive plan and $418.8K in salary.

Rankings

In 2020, Jonathan Drachman's compensation ranked 2,522nd out of 13,090 executives tracked by ExecPay. In other words, Drachman earned more than 80.7% of executives.

ClassificationRankingPercentile
All
2,522
out of 13,090
81st
Division
Manufacturing
966
out of 5,621
83rd
Major group
Chemicals And Allied Products
348
out of 2,254
85th
Industry group
Drugs
299
out of 1,954
85th
Industry
Pharmaceutical Preparations
217
out of 1,459
85th
Source: SEC filing on March 31, 2022.

Drachman's colleagues

We found one more compensation record of an executive who worked with Jonathan Drachman at Aquinox Pharmaceuticals in 2020.

2020

Robert Ho

Aquinox Pharmaceuticals

Chief Financial Officer

News

You may also like